Global Plasma Fractionation Industry (2020 to 2027) - Market Trajectory & Analytics

News provided by

Jul 24, 2020, 12:15 ET

DUBLIN, July 24, 2020 /PRNewswire/ -- The "Plasma Fractionation - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

The publisher brings years of research experience to this 6th edition of the report. The 188-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Global Plasma Fractionation Market to Reach US$31.9 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for Plasma Fractionation estimated at US$22.1 Billion in the year 2020, is projected to reach a revised size of US$31.9 Billion by 2027, growing at a CAGR of 5.4% over the analysis period 2020-2027.

Intravenous Immunoglobulins, one of the segments analyzed in the report, is projected to grow at a 5.8% CAGR to reach US$10.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Coagulation Factor Concentrates segment is readjusted to a revised 6.7% CAGR for the next 7-year period. This segment currently accounts for a 24.1% share of the global Plasma Fractionation market.

The U.S. Accounts for Over 29.5% of Global Market Size in 2020, While China is Forecast to Grow at a 5% CAGR for the Period of 2020-2027

The Plasma Fractionation market in the U.S. is estimated at US$6.5 Billion in the year 2020. The country currently accounts for a 29.49% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$5.6 Billion in the year 2027 trailing a CAGR of 5% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.1% and 4.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR while Rest of European market (as defined in the study) will reach US$5.6 Billion by the year 2027.

Albumin Segment Corners a 19.9% Share in 2020

In the global Albumin segment, USA, Canada, Japan, China and Europe will drive the 5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$3.5 Billion in the year 2020 will reach a projected size of US$5 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.7 Billion by the year 2027.

Competitors identified in this market include, among others

Bio Products Laboratory Ltd.
Biotest AG
China Biologic Products, Inc.
CSL Limited
Green Cross Corporation
Grifols SA
Japan Blood Products Organization
Kedrion SpA
LFB SA
Octapharma AG
Sanquin
Shanghai RAAS Blood Products Co., Ltd.
Shire PLC

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares
Plasma Fractionation Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

Total Companies Profiled: 47

For more information about this report visit https://www.researchandmarkets.com/r/58hio1

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets